|
Muscle disease
Citations 91-100 of 283 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
Valosin-containing protein gene mutations: Clinical and neuropathologic features
- L. Guyant-Maréchal, A. Laquerrière, C. Duyckaerts, C. Dumanchin, J. Bou, F. Dugny, I. Le Ber, T. Frébourg, D. Hannequin, and D. Campion
Neurology 2006; 67: 644-651.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Do carriers of PYGM mutations have symptoms of McArdle disease?
- Susanne Tvede Andersen, Morten Dunø, Marianne Schwartz, and John Vissing
Neurology 2006; 67: 716-718.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Progressive depletion of mtDNA in mitochondrial myopathy
- Steve E. Durham, Denise T. Brown, Douglass M. Turnbull, and Patrick F. Chinnery
Neurology 2006; 67: 502-504.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2)
- C. Gaul, T. Schmidt, G. Windisch, T. Wieser, T. Müller, S. Vielhaber, S. Zierz, and B. Leplow
Neurology 2006; 67: 350-352.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Oncogenic osteomalacia: Muscular weakness and multiple fractures
- Shafeeq S. Ladha, Michael D. Whitaker, and E. Peter Bosch
Neurology 2006; 67: 364-365.
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Mitochondrial disease in adults: A scale to monitor progression and treatment
- A. M. Schaefer, C. Phoenix, J. L. Elson, R. McFarland, P. F. Chinnery, and D. M. Turnbull
Neurology 2006; 66: 1932-1934.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Andersen–Tawil syndrome: Definition of a neurocognitive phenotype
- G. Yoon, L. Quitania, J. H. Kramer, Y. H. Fu, B. L. Miller, and L. J. Ptácek
Neurology 2006; 66: 1703-1710.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia
- C. Fernandez, A. Maues de Paula, D. Figarella-Branger, M. Krahn, R. Giorgi, B. Chabrol, M. -F. Monfort, J. Pouget, and J. -F. Pellissier
Neurology 2006; 66: 1585-1587.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Mycophenolate mofetil in dermatomyositis: Is it safe?
- J. Rowin, A. A. Amato, N. Deisher, J. Cursio, and M. N. Meriggioli
Neurology 2006; 66: 1245-1247.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions
- M. -E. Arsenault, C. Prévost, A. Lescault, C. Laberge, J. Puymirat, and J. Mathieu
Neurology 2006; 66: 1248-1250.
[Abstract]
[Full text]
[PDF]
|
|
